4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Body Weight in 11 studies
4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5 mg/kg) on (i) anxiety-related behaviour in an elevated plus-maze, and (ii) specific [3H]ketanserin binding at central 5-HT2A receptors, in Roman rats." | 7.69 | Repeated DOI and SR 46349B treatments do not affect elevated plus-maze anxiety despite opposite effects on cortical 5-HT2A receptors. ( Chaouloff, F; Kulikov, A; Mormède, P, 1997) |
| "5 mg/kg) on (i) anxiety-related behaviour in an elevated plus-maze, and (ii) specific [3H]ketanserin binding at central 5-HT2A receptors, in Roman rats." | 3.69 | Repeated DOI and SR 46349B treatments do not affect elevated plus-maze anxiety despite opposite effects on cortical 5-HT2A receptors. ( Chaouloff, F; Kulikov, A; Mormède, P, 1997) |
| "Pretreatment with desipramine and mianserin in combination induced the most intense 5-HT syndrome and the greatest fall in colonic temperature after injection of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT)." | 1.29 | Chronic, combined treatment with desipramine and mianserin: enhanced 5-HT1A receptor function and altered 5-HT1A/5-HT2 receptor interaction in rats. ( Lund, A; Mjellem, N, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishiguro, T | 1 |
| Sakata-Haga, H | 1 |
| Fukui, Y | 1 |
| Shi, J | 1 |
| Landry, M | 1 |
| Carrasco, GA | 1 |
| Battaglia, G | 2 |
| Muma, NA | 2 |
| Basselin, M | 1 |
| Fox, MA | 1 |
| Chang, L | 1 |
| Bell, JM | 1 |
| Greenstein, D | 1 |
| Chen, M | 1 |
| Murphy, DL | 1 |
| Rapoport, SI | 1 |
| Damjanoska, KJ | 1 |
| Heidenreich, BA | 1 |
| Kindel, GH | 1 |
| D'Souza, DN | 1 |
| Zhang, Y | 1 |
| Garcia, F | 1 |
| Wolf, WA | 1 |
| Van de Kar, LD | 1 |
| Sikorski, BW | 1 |
| James, GM | 1 |
| Glance, SD | 1 |
| Hodgson, WC | 1 |
| King, RG | 1 |
| Baudrie, V | 1 |
| De Vry, J | 1 |
| Broqua, P | 1 |
| Schmidt, B | 1 |
| Chaouloff, F | 2 |
| Glaser, T | 1 |
| Lund, A | 1 |
| Mjellem, N | 1 |
| Kulikov, A | 1 |
| Mormède, P | 1 |
| Bollweg, G | 1 |
| Sparber, SB | 1 |
| Kozuru, T | 1 |
| Kagaya, A | 2 |
| Takebayashi, M | 1 |
| Horiguchi, J | 1 |
| Yamawaki, S | 2 |
| Kouhata, S | 1 |
| Nakae, S | 1 |
| Nakata, Y | 1 |
11 other studies available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Body Weight
| Article | Year |
|---|---|
A 5-HT2A/2C receptor agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, mitigates developmental neurotoxicity of ethanol to serotonergic neurons.
Topics: Amphetamines; Animals; Biogenic Monoamines; Body Weight; Brain; Cell Count; Cell Differentiation; Et | 2016 |
Sustained treatment with a 5-HT(2A) receptor agonist causes functional desensitization and reductions in agonist-labeled 5-HT(2A) receptors despite increases in receptor protein levels in rats.
Topics: Adrenocorticotropic Hormone; Amphetamines; Analysis of Variance; Animals; Autoradiography; Body Weig | 2008 |
Imaging elevated brain arachidonic acid signaling in unanesthetized serotonin transporter (5-HTT)-deficient mice.
Topics: Amphetamines; Analysis of Variance; Animals; Arachidonic Acid; Autoradiography; Body Weight; Brain; | 2009 |
Agonist-induced serotonin 2A receptor desensitization in the rat frontal cortex and hypothalamus.
Topics: Amphetamines; Animals; Body Weight; Hypothalamus; Male; Paraventricular Hypothalamic Nucleus; Prefro | 2004 |
Effect of endothelium on diabetes-induced changes in constrictor responses mediated by 5-hydroxytryptamine in rat aorta.
Topics: Amphetamines; Animals; Aorta; Arginine; Body Weight; Diabetes Mellitus, Experimental; Endothelium; I | 1993 |
Subchronic treatment with anxiolytic doses of the 5-HT1A receptor agonist ipsapirone does not affect 5-HT2 receptor sensitivity in the rat.
Topics: Administration, Oral; Amphetamines; Animals; Anti-Anxiety Agents; Blood Glucose; Body Weight; Cortic | 1993 |
Chronic, combined treatment with desipramine and mianserin: enhanced 5-HT1A receptor function and altered 5-HT1A/5-HT2 receptor interaction in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Behavior, Animal; Body Temperature; B | 1993 |
Repeated DOI and SR 46349B treatments do not affect elevated plus-maze anxiety despite opposite effects on cortical 5-HT2A receptors.
Topics: Amphetamines; Animals; Anxiety; Behavior, Animal; Body Weight; Cerebral Cortex; Female; Fluorobenzen | 1997 |
Relationships between midembryonic 5-HT2 agonist and/or antagonist exposure and detour learning by chickens.
Topics: Amphetamines; Animals; Behavior, Animal; Body Weight; Chick Embryo; Chickens; Female; Humans; Learni | 1998 |
Chronic electroconvulsive shock decreases (+/-) 1-(4-iodo-2,5-dimethoxyphenyl)-2-aminopropane hydrochloride (DOI)-induced wet-dog shake behaviors of dexamethasone-treated rats.
Topics: Amphetamines; Animals; Behavior, Animal; Binding Sites; Body Weight; Corticosterone; Dexamethasone; | 2000 |
Effect of acute lipopolysaccharide administration on (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2 aminopropane-induced wet dog shake behavior in rats: comparison with body weight change and locomotor activity.
Topics: Amphetamines; Animals; Body Weight; Drug Administration Schedule; Endotoxins; Indomethacin; Lipopoly | 2001 |